Search results
Results from the WOW.Com Content Network
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn , a legacy division of Pfizer , on November 16, 2020.
Viatris was formed with the merger of Mylan and Pfizer's Upjohn business and has generic and key branded drugs in its portfolio, including erectile dysfunction drug Viagra, anti-anxiety medication ...
Viatris also raised its full-year new product revenue forecast. It now expects a range of $500 million to $800 million, up from the previous projection of $450 million to $550 million.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
In November 2019, Mylan & Upjohn announced that the name of the new company would be Viatris. [84] [85] The company continued sales of Mylan's more than 7,500 products, including biosimilars, generics, brand and over-the-counter remedies, with brands including the Epi-Pen, Viagra, Lipitor and Celebrex. [86] [87] [88]
Viatris had divested its biosimilar business in the early part of last year. Including that deal and the latest divestitures, the company would receive about $6.94 billion in proceeds.
Viatris (medical) Large private companies. 4moms (juvenile/robotics consumer goods) 84 Lumber (retail/consumer goods) American Bridge Company (industrial)
AXP PE Ratio data by YCharts. And it isn't just the P/E ratio that's elevated. The price-to-sales, price-to-cash flow, price-to-book value, and price-to-earnings ratios are all above their five ...